HIV-associated Pneumocystis pneumonia - PubMed (original) (raw)

Review

HIV-associated Pneumocystis pneumonia

Laurence Huang et al. Proc Am Thorac Soc. 2011 Jun.

Abstract

During the past 30 years, major advances have been made in our understanding of HIV/AIDS and Pneumocystis pneumonia (PCP), but significant gaps remain. Pneumocystis is classified as a fungus and is host-species specific, but an understanding of its reservoir, mode of transmission, and pathogenesis is incomplete. PCP remains a frequent AIDS-defining diagnosis and is a frequent opportunistic pneumonia in the United States and in Europe, but comparable epidemiologic data from other areas of the world that are burdened with HIV/AIDS are limited. Pneumocystis cannot be cultured, and bronchoscopy with bronchoalveolar lavage is the gold standard procedure to diagnose PCP, but noninvasive diagnostic tests and biomarkers show promise that must be validated. Trimethoprim-sulfamethoxazole is the recommended first-line treatment and prophylaxis regimen, but putative trimethoprim-sulfamethoxazole drug resistance is an emerging concern. The International HIV-associated Opportunistic Pneumonias (IHOP) study was established to address these knowledge gaps. This review describes recent advances in the pathogenesis, epidemiology, diagnosis, and management of HIV-associated PCP and ongoing areas of clinical and translational research that are part of the IHOP study and the Longitudinal Studies of HIV-associated Lung Infections and Complications (Lung HIV).

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Annual number of microscopically confirmed cases of Pneumocystis pneumonia (PCP) diagnosed at San Francisco General Hospital, 1990–2009. ART = antiretroviral therapy.

Figure 2.

Figure 2.

Chest radiograph demonstrating the characteristic bilateral, symmetric granular opacities in an HIV-infected patient with Pneumocystis pneumonia (courtesy of L. Huang, used with permission).

Figure 3.

Figure 3.

Chest high-resolution computed tomograph demonstrating the characteristic ground glass opacities in an HIV-infected patient with Pneumocystis pneumonia who had a normal chest radiograph (courtesy of L. Huang, used with permission).

Similar articles

Cited by

References

    1. Kovacs JA, Masur H. Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA 2009;301:2578–2585. - PubMed
    1. Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, Cumsille F, Gigliotti F. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001;32:855–861. - PubMed
    1. Larsen HH, von Linstow ML, Lundgren B, Hogh B, Westh H, Lundgren JD. Primary Pneumocystis infection in infants hospitalized with acute respiratory tract infection. Emerg Infect Dis 2007;13:66–72. - PMC - PubMed
    1. Meuwissen JH. Infections with Pneumocystis carinii. Natl Cancer Inst Monogr 1976;43:133–136. - PubMed
    1. Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978;61:35–41. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources